Browsing: drug pricing

UK Trade Secretary has launched a fierce critique of the pharmaceutical industry amid heated price negotiations, highlighting soaring drug costs and demanding fairer pricing as critical trade talks loom

Indian pharma stocks plunged sharply following President Trump’s announcement of new drug tariffs. However, analysts urge investors not to panic, highlighting that this sell-off is largely sentiment-driven and the sector’s strong fundamentals remain intact despite the market turbulence

Eli Lilly has temporarily paused UK orders of its diabetes medication Mounjaro ahead of an upcoming price hike, aiming to prevent potential stockpiling. This move carefully manages supply to meet rising demand while preparing for the new pricing structure

Brazil’s groundbreaking update to drug pricing regulations is shaking up the pharmaceutical landscape! Companies are now required to present stronger evidence showcasing their products’ effectiveness and cost-efficiency. This pivotal change could transform market dynamics and enhance access to vital medications throughout the country.